GILL SIMBA 4
4 · Evelo Biosciences, Inc. · Filed May 10, 2023
Insider Transaction Report
Form 4
GILL SIMBA
DirectorPresident & CEO
Transactions
- Sale
Common Stock
2023-05-08$0.13/sh−3,537$444→ 58,512 total
Footnotes (2)
- [F1]The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 instruction entered into by the Reporting Person on December 7, 2022, solely with the intent to cover withholding taxes in connection with the vesting of certain previously reported restricted stock units.
- [F2]The price reported in Column 4 is an average price. These shares were sold in multiple transactions at prices within the range of $0.12 to $0.13, inclusive. The reporting person undertakes to provide to the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote of this Form 4.